Table 6.
In vivo effects of tilapia-derived peptide mixtures and protein hydrolysates a.
Sample | Effective Dosage (per kg Body Weight) |
In Vivo Model | Key Findings | Reference |
---|---|---|---|---|
Collagen polypeptides (<3 kDa) prepared from tilapia skin using neutral protease and papain | 500–2000 mg | Mouse model of aging induced by D-galactose |
|
[23] |
Tilapia gelatin hydrolysate prepared with Properase E® | 100–200 mg | UV-induced skin photoaging mice |
|
[70,71] |
Commercial tilapia collagen peptide powder, in combination with antioxidant supplements | Collagen peptide, 1.2 g; vitamin C, 100 mg; vitamin E, 2.66 mg; astaxanthin, 2.5 mg | UV-induced skin photoaging mice |
|
[24] |
Tilapia skin collagen hydrolysate prepared with Alcalase® | 0.85–1.70 g | Alloxan-induced diabetic mice |
|
[22] |
Tilapia collagen peptide mixture TY001 | 20–60 g | STZ-induced diabetic mice |
|
[69] |
Tilapia viscera hydrolysate extract prepared with Alcalase® | 150–300 mg | DOCA-salt-induced hypertensive rats |
|
[44] |
Tilapia skin collagen hydrolysate prepared with Alcalase® | 250–2500 mg | Mice subjected to exhaustive swimming assay |
|
[72] |
a CAT, catalase; DOCA, deoxycorticosterone acetate; GSH-Px, glutathione peroxidase; Hyp, hydroxyproline; IL, interleukin; LPO, lipid peroxidation; MDA, malondialdehyde; ROS, reactive oxygen species; SOD, superoxide dismutase; STZ, streptozotocin.